What's new about ventilator-associated pneumonia

Anesthesiology

Volumn 94, Issue 4, 2001, Pages 551-553

  Kollef, Marin H ^a,b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Medical Intensive Care Unit   (United States)

^c BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; EDITORIAL; HOSPITAL INFECTION; HOSPITALIZATION; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; RISK FACTOR;

EID: 0035091091     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200104000-00004     Document Type: Editorial

References (39)

1. Is ventilator-associated pneumonia an independent risk factor for death?
2. Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay
3. Epidemiology of ventilator-associated pneumonia
4. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System
5. Epidemiology and risk factors for nosocomial pneumonia
6. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria
7. The impact of nosocomial infections on patient outcomes following cardiac surgery
8. Mortality associated with ventilator, associated pneumonia in an adult intensive care unit: A prospective 135 matched-pairs cohort study
9. A comparative analysis of patients with early-onset versus late-onset nosocomial pneumonia (NP) in the ICU setting
10. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting
11. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group
12. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia
13. The impact of routine microbial investigation in ventilator-associated pneumonia
14. Multicenter prospective study of ventilator-associated pneumonia during acute respiratory, distress syndrome-incidence, prognosis, and risk factors
15. Utilizing quality assurance as a tool for reducing the risk of nosocomial ventilator-associated pneumonia
16. An effective continuous quality improvement approach to the prevention of ventilator-associated pneumonia
17. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: A randomized trial
18. A randomized study assessing the systematic search for maxillary sinusitis in nasotracheally mechanically ventilated patients: Influence of nosocomial maxillary sinusitis on the occurrence of ventilator associated pneumonia
19. Risk factors and clinical relevance of nosocomial maxillary sinusitis in the critically ill
20. A comparison of noninvasive positive pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure
21. Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease: A randomized, controlled trial
22. Protocol weaning of mechanical ventilation in medical and surgical patients by respiratory care practitioners and nurses: Effect on weaning time and incidence of ventilator-associated pneumonia
23. Implications of endotracheal tube biofilm for ventilator-associated pneumonia
24. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic 'blind' bronchoalveolar lavage fluid
25. Clinical criteria in the diagnosis of ventilator-associated pneumonia
26. The accuracy of elevated concentrations of endotoxin in bronchoalveolar lavage fluid for the rapid diagnosis of gram-negative pneumonia
27. Protected-specimen brush technique in the diagnosis of ventilator-associated pneumonia
28. Bronchoscopic BAL in the diagnosis of ventilator-associated pneumonia
29. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: A pilot study
30. Impact of quantitative invasive diagnostic techniques in the management and out of mechanically ventilated patients with suspected pneumonia
31. Noninvasive versus invasive microbial investigation ventilator-associated pneumonia: Evaluation of outcome
32. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: A randomized trial
33. Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients
34. Short course empiric antibiotic therapy for pulmonary infiltrates in the intensive care unit: A proposed solution for indiscriminate antibiotic prescription
35. Improving antibiotic utilization for the treatment of ventilator-associated pneumonia using a clinical guideline
36. Incidence of anaerobes in ventilator-associated pneumonia with use of a protected specimen brush
37. The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: A prospective study
38. Treatment of severe pneumonia in hospitalized patients: Results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenemcilastin
39. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient